Kenvue Inc. (NYSE: KVUE) Faces Downgrade Amid Competitive Market
Jefferies downgrades Kenvue Inc. (NYSE: KVUE) from Buy to Hold, indicating a cautious outlook.The average 1-year target price among analysts is set at approximately $20.23.Other financial institutions like Citigroup and Canaccord Genuity Group have also revised their price targets and ratings, reflecting a tempered view on Kenvue's future performance.Kenvue Inc. (NYSE: KVUE) is a prominent player in the consumer health industry, offering a range of products that cater to personal health and wellness. The co ...